117 related articles for article (PubMed ID: 32944786)
1. Extracapsular Spread in Melanoma Lymphadenopathy: Prognostic Implications, Classification, and Management.
Lo M; Robinson A; Wade R; Peach H; Dewar D; Heaton M; Moncrieff M
Ann Surg Oncol; 2021 Mar; 28(3):1642-1653. PubMed ID: 32944786
[TBL] [Abstract][Full Text] [Related]
2. Diversity of stage III melanoma in the era of sentinel lymph node biopsy.
Egger ME; Callender GG; McMasters KM; Ross MI; Martin RC; Edwards MJ; Urist MM; Noyes RD; Sussman JJ; Reintgen DS; Stromberg AJ; Scoggins CR
Ann Surg Oncol; 2013 Mar; 20(3):956-63. PubMed ID: 23064795
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Role of Multiple Lymphatic Basin Drainage in Sentinel Lymph Node-Negative Trunk Melanoma Patients: A Multicenter Study from the Italian Melanoma Intergroup.
Ribero S; Osella-Abate S; Pasquali S; Rossi CR; Borgognoni L; Piazzalunga D; Solari N; Schiavon M; Brandani P; Ansaloni L; Ponte E; Silan F; Sommariva A; Bellucci F; Macripò G; Quaglino P
Ann Surg Oncol; 2016 May; 23(5):1708-15. PubMed ID: 26597362
[TBL] [Abstract][Full Text] [Related]
4. Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients.
Rousseau DL; Ross MI; Johnson MM; Prieto VG; Lee JE; Mansfield PF; Gershenwald JE
Ann Surg Oncol; 2003 Jun; 10(5):569-74. PubMed ID: 12794025
[TBL] [Abstract][Full Text] [Related]
5. The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique.
Rutkowski P; Szydłowski K; Nowecki ZI; Sałamacha M; Goryń T; Mitręga-Korab B; Pieńkowski A; Dziewirski W; Zdzienicki M
World J Surg Oncol; 2015 Oct; 13():299. PubMed ID: 26462471
[TBL] [Abstract][Full Text] [Related]
6. Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma.
Fincher TR; McCarty TM; Fisher TL; Preskitt JT; Lieberman ZH; Stephens JF; O'Brien JC; Kuhn JA
Am J Surg; 2003 Dec; 186(6):675-81. PubMed ID: 14672778
[TBL] [Abstract][Full Text] [Related]
7. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma.
Gershenwald JE; Mansfield PF; Lee JE; Ross MI
Ann Surg Oncol; 2000 Mar; 7(2):160-5. PubMed ID: 10761797
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
[TBL] [Abstract][Full Text] [Related]
9. Risk Stratification of Sentinel Node Metastasis Disease Burden and Phenotype in Stage III Melanoma Patients.
Hussain Z; Heaton MJ; Snelling AP; Nobes JP; Gray G; Garioch JJ; Moncrieff MD
Ann Surg Oncol; 2023 Mar; 30(3):1808-1819. PubMed ID: 36445500
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes--one institution's experience.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Melanoma Res; 2003 Feb; 13(1):35-43. PubMed ID: 12569283
[TBL] [Abstract][Full Text] [Related]
12. Thin Melanoma with Nodal Involvement: Analysis of Demographic, Pathologic, and Treatment Factors with Regard to Prognosis.
Karakousis G; Gimotty PA; Bartlett EK; Sim MS; Neuwirth MG; Fraker D; Czerniecki BJ; Faries MB
Ann Surg Oncol; 2017 Apr; 24(4):952-959. PubMed ID: 27807729
[TBL] [Abstract][Full Text] [Related]
13. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
[TBL] [Abstract][Full Text] [Related]
14. The role of sentinel lymph node biopsy in the management of invasive extramammary Paget's disease: Multi-center, retrospective study of 151 patients.
Fujisawa Y; Yoshino K; Kiyohara Y; Kadono T; Murata Y; Uhara H; Hatta N; Uchi H; Matsushita S; Takenouchi T; Hayashi T; Fujimoto M; Ohara K
J Dermatol Sci; 2015 Jul; 79(1):38-42. PubMed ID: 25944505
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma.
Stiegel E; Xiong D; Ya J; Funchain P; Isakov R; Gastman B; Vij A
J Am Acad Dermatol; 2018 May; 78(5):942-948. PubMed ID: 29408526
[TBL] [Abstract][Full Text] [Related]
16. Single-institution experience in the management of patients with clinical stage I and II cutaneous melanoma: results of sentinel lymph node biopsy in 240 cases.
Rex J; Paradelo C; Mangas C; Hilari JM; Fernández-Figueras MT; Fraile M; Alastrué A; Ferrándiz C
Dermatol Surg; 2005 Nov; 31(11 Pt 1):1385-93. PubMed ID: 16416605
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018).
Sohng C; Sim HB; Kim JY; Lim Y; Han MH; Lee H; Ahn BC; Huh S; Lee SJ
Asia Pac J Clin Oncol; 2021 Feb; 17(1):115-122. PubMed ID: 33079454
[TBL] [Abstract][Full Text] [Related]
18. Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study.
Tejera-Vaquerizo A; Ribero S; Puig S; Boada A; Paradela S; Moreno-Ramírez D; Cañueto J; de Unamuno B; Brinca A; Descalzo-Gallego MA; Osella-Abate S; Cassoni P; Carrera C; Vidal-Sicart S; Bennássar A; Rull R; Alos L; Requena C; Bolumar I; Traves V; Pla Á; Fernández-Orland A; Jaka A; Fernández-Figueres MT; Hilari JM; Giménez-Xavier P; Vieira R; Botella-Estrada R; Román-Curto C; Ferrándiz L; Iglesias-Pena N; Ferrándiz C; Malvehy J; Quaglino P; Nagore E;
Cancer Med; 2019 Aug; 8(9):4235-4244. PubMed ID: 31215168
[TBL] [Abstract][Full Text] [Related]
19. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
20. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]